In 2023, the market for skin replacements and substitutes generated USD 1,178.2 million in revenue. It is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2030, reaching USD 1,869.2 million by the end of the forecast period. This growth is driven by increasing spending on cosmetic enhancements, expanding global population, rising incidences of burns and skin diseases, and longer life expectancy worldwide.
The increasing prevalence of burns is a significant driver of market growth. According to the World Health Organization (WHO), approximately 0.18 million individuals die annually from burns, with over 1 million affected in India alone. While high-income countries report fewer burn cases, they remain a major cause of disability-adjusted life years in low- and middle-income countries. Non-fatal burns also contribute significantly to morbidity, with a majority occurring accidentally in homes and workplaces.
Acellular products are expected to dominate the skin replacements market by 2030, capturing about 45% of the revenue share. Acellular skin substitutes are versatile across demographics, suitable for pediatric populations, and applicable to both excised and chronic wounds.
Download free report sample at: https://www.psmarketresearch.com/market-analysis/skin-replacement-and-substitutes-market/report-sample
Government-led campaigns worldwide promoting the use of biologics for wound healing are driving demand for acellular alternatives. The skin, as the body's largest organ comprising the dermis and epidermis, plays a crucial role in protecting against environmental factors and pathogens. Increasing incidences of infections, burns, and dermatological conditions underscore the global demand for biological skin substitutes.
Biological skin graft materials include animal and human tissue, synthetic materials, and a range of classifications (class I, II, and III) based on their properties and applications. Class I materials act as temporary barriers, while class II includes durable substitutes such as processed skin or collagen-based matrices from various sources.
Geographically, North America led the market in 2023 with approximately USD 0.6 billion in revenue. Factors driving this leadership include high skincare expenditure, increasing awareness of advanced treatments, rapid healthcare technological advancements, and the presence of sophisticated medical facilities.
Sign in to leave a comment.